Anti-human CSF2 / GM-CSF (Theraclone patent Anti-GM-CSF Biosimilar) ATP dependent helicase RENT1 Target Name VEGF Target Uniprot

Target Name VEGF Target Uniprot P15692 Overview

Two closely related variants of human caldesmon have been identified which differ in their electrophorectic mobility and cellular distribution

catestatin

inhibiting cell cycle progression from G1 to S phase

Background

Anti-human CSF2 / GM-CSF (Theraclone patent Anti-GM-CSF Biosimilar) ATP dependent helicase RENT1 Target Name VEGF Target UniprotApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name CSF2 GM CSF Target Uniprot P04141 Overview Catalog# BIO0787SM Product Name Anti human CSF2 GM CSF (Theraclone patent Anti GM CSF Biosimilar) Specifications Conjugation None Clone# Theraclone patent Anti GM CSF Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution